A Phase 1 interventional study of Yarrow and moringa mixture in Gingivitis, sponsored by Deraya University. Completed at 1 site in Egypt. Open to participants aged 25 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-10-06.
Sponsored by Deraya University · Phase 1, Interventional, and Treatment
A double-blind, prospective, randomized, intra-individual comparative, single-center clinical study was conducted. Participants were placed in parallel groups, and the study was performed in the Department of Operative Dentistry and Periodontology, Dental School and Hospital, Minia university to compare the antibacterial activity of yarrow Moringa herbal combinations nanoparticles in compared to Chlorhexidine as a potential treatment for gingivitis.
590 studies on the registry are indexed under Gingivitis; 104 are open to participants now.
This study's enrollment of 40 is below the median of 64 across 478 interventional studies indexed under Gingivitis.
Browse Gingivitis studies →Deraya University is the lead sponsor of 48 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Bucco-adhesive films with Yarrow and Moringa extract nanoparticles
Drug: Yarrow and moringa mixture
Cholorohexiden oral gargles
Drug: Yarrow and moringa mixture
yarrow and moringa mixture nano particles loaded on buccal film
antibacterial and anti inflammatory activities
scoring of erthymia and pain (no pain=0) and the other end (worst pain=10).
Time frame: two weeks
This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Deraya University